Sign inGet started

HANNAH ALISON L.

Insider CIK 1645600 · RIGL EVP, Chief Medical Officer, Director · NEO Director · CTMX Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RIGL RIGEL PHARMACEUTICALS INC A Award2026-07-082026-07-1024,400— $035,025SEC↗
RIGL RIGEL PHARMACEUTICALS INC A Award2026-05-152026-05-195,750— $016,375SEC↗
NEO NEOGENOMICS INC A Award deriv2025-06-012025-06-0316,107— $016,107SEC↗
NEO NEOGENOMICS INC A Award deriv2025-06-012025-06-0323,077— $023,077SEC↗
NEO NEOGENOMICS INC M Exercise deriv2025-06-012025-06-0312,254— $00SEC↗
NEO NEOGENOMICS INC A Award2025-06-012025-06-0312,254— $0131,023SEC↗
NEO NEOGENOMICS INC M Exercise2025-06-012025-06-0312,254— $0131,023SEC↗
RIGL RIGEL PHARMACEUTICALS INC A Award deriv2025-05-232025-05-283,000— $03,000SEC↗
RIGL RIGEL PHARMACEUTICALS INC A Award2025-05-232025-05-282,500— $010,625SEC↗
NEO NEOGENOMICS INC M Exercise deriv2024-08-102024-08-1311,336— $00SEC↗
NEO NEOGENOMICS INC M Exercise2024-08-102024-08-1311,336— $0118,769SEC↗
NEO NEOGENOMICS INC A Award deriv2024-06-012024-06-048,672— $08,672SEC↗
NEO NEOGENOMICS INC A Award deriv2024-06-012024-06-0412,254— $012,254SEC↗
RIGL RIGEL PHARMACEUTICALS INC A Award deriv2024-05-252024-05-2930,000— $030,000SEC↗
RIGL RIGEL PHARMACEUTICALS INC A Award2024-05-252024-05-2925,000— $081,250SEC↗
NEO NEOGENOMICS INC A Award deriv2023-08-102023-08-1411,336— $011,336SEC↗
NEO NEOGENOMICS INC A Award deriv2023-08-102023-08-148,353— $08,353SEC↗
RIGL RIGEL PHARMACEUTICALS INC A Award deriv2023-05-262023-07-1230,000— $030,000SEC↗
RIGL RIGEL PHARMACEUTICALS INC A Award2023-05-262023-07-1225,000— $056,250SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2022-07-202022-07-215,602$1.42 $8.0K31,898SEC↗
CTMX CytomX Therapeutics, Inc. A Award2022-07-192022-07-2115,000— $037,500SEC↗
NEO NEOGENOMICS INC A Award deriv2022-06-102022-06-1413,882— $013,882SEC↗
NEO NEOGENOMICS INC A Award2022-06-102022-06-1415,556— $0107,433SEC↗
RIGL RIGEL PHARMACEUTICALS INC A Award deriv2022-05-202022-05-2330,000— $030,000SEC↗
RIGL RIGEL PHARMACEUTICALS INC A Award2022-05-202022-05-2325,000— $031,250SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2022-02-022022-02-04135,000— $0135,000SEC↗
CTMX CytomX Therapeutics, Inc. A Award2022-02-022022-02-0422,500— $022,500SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2021-10-242021-10-2630,000— $030,000SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2021-10-242021-10-2640,000— $040,000SEC↗
NEO NEOGENOMICS INC A Award deriv2021-06-022021-06-043,714— $03,714SEC↗
NEO NEOGENOMICS INC A Award2021-06-022021-06-043,081— $091,877SEC↗
RIGL RIGEL PHARMACEUTICALS INC A Award deriv2021-05-192021-05-217,500— $07,500SEC↗
RIGL RIGEL PHARMACEUTICALS INC A Award2021-05-192021-05-216,250— $06,250SEC↗
RIGL RIGEL PHARMACEUTICALS INC A Award deriv2021-05-142021-05-1880,000— $080,000SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2021-02-262021-03-02175,000— $0175,000SEC↗
NEO NEOGENOMICS INC M Exercise deriv2020-08-062020-08-1010,000— $00SEC↗
NEO NEOGENOMICS INC M Exercise2020-08-062020-08-1010,000$7.27 $72.7K88,796SEC↗
NEO NEOGENOMICS INC A Award deriv2020-05-282020-06-013,448— $03,448SEC↗
NEO NEOGENOMICS INC A Award2020-05-282020-06-012,698— $078,796SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2020-02-032020-02-05250,000— $0250,000SEC↗
NEO NEOGENOMICS INC M Exercise deriv2019-09-092019-09-113,333$6.66 $22.2K0SEC↗
NEO NEOGENOMICS INC M Exercise deriv2019-09-092019-09-118,333$9.11 $75.9K0SEC↗
NEO NEOGENOMICS INC M Exercise2019-09-092019-09-118,333$9.11 $75.9K76,098SEC↗
NEO NEOGENOMICS INC M Exercise2019-09-092019-09-113,333$6.66 $22.2K67,765SEC↗
NEO NEOGENOMICS INC A Award deriv2019-06-062019-06-104,269— $04,269SEC↗
NEO NEOGENOMICS INC A Award2019-06-062019-06-103,419— $064,432SEC↗
NEO NEOGENOMICS INC A Award deriv2018-06-012018-06-053,017— $03,017SEC↗
NEO NEOGENOMICS INC A Award2018-06-012018-06-0515,564— $061,013SEC↗
NEO NEOGENOMICS INC X Exercise deriv2017-08-092017-10-036,667$6.66 $44.4K3,333SEC↗
NEO NEOGENOMICS INC M Exercise2017-08-092017-10-036,667$6.66 $44.4K45,449SEC↗
NEO NEOGENOMICS INC P Buy2017-07-272017-07-3120,000$9.19 $183.8K38,782SEC↗
NEO NEOGENOMICS INC C Conversion deriv2017-05-302017-05-302,150— $00SEC↗
NEO NEOGENOMICS INC C Conversion deriv2017-05-302017-05-305,072— $00SEC↗
NEO NEOGENOMICS INC M Exercise2017-05-302017-05-307,222— $018,782SEC↗
NEO NEOGENOMICS INC A Award deriv2017-05-252017-05-308,667— $08,667SEC↗
NEO NEOGENOMICS INC A Award deriv2017-05-252017-05-3010,000$7.27 $72.7K10,000SEC↗
NEO NEOGENOMICS INC A Award deriv2016-07-282016-08-015,072— $07,222SEC↗
NEO NEOGENOMICS INC A Award deriv2016-07-282016-08-018,333$9.11 $75.9K25,555SEC↗
NEO NEOGENOMICS INC A Award2016-04-202016-05-042,150$7.15 $15.4K13,710SEC↗
NEO NEOGENOMICS INC P Buy2016-03-032016-03-0410,000$6.90 $69.0K11,560SEC↗
NEO NEOGENOMICS INC A Award deriv2015-07-152015-07-1610,000$6.66 $66.6K10,000SEC↗